Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29277393 | 0.80 | MAPT (0.32) | — | |
| SCHEMBL2890927 | 0.75 | CA12 (0.55) | CA12CA1CA2CA9 | |
| SCHEMBL29088214 | 0.73 | CA12 (0.53) | CA12CA1CA2CA9 | |
| SCHEMBL2883256 | 0.73 | CA12 (0.41) | CA12CA1CA2CA9 | |
| SCHEMBL15301854 | 0.69 | CA12 (0.43) | CA12CA1CA2CA9 | |
| SCHEMBL2888771 | 0.69 | CA12 (0.46) | CA12CA1CA2CA9 | |
| SCHEMBL28532559 | 0.67 | CA12 (0.41) | CA12CA1CA2CA9 | |
| SCHEMBL2453463 | 0.66 | HTT (0.33) | — | |
| SCHEMBL30838856 | 0.66 | CA12 (0.46) | CA12CA1CA2CA9 | |
| SCHEMBL18420648 | 0.65 | MEN1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8211252-B2 | Furazane derivatives, preparation thereof and energetic compositions containing them | EURENCO (FR) | 2012-07-03 | — | — | US | claimed |
| US-20100132856-A1 | FURAZANE DERIVATIVES, PREPARATION THEREOF AND ENERGETIC COMPOSITIONS CONTAINING THEM | SNPE MATERIAUX ENERGETIQUES (FR) | 2010-06-03 | — | — | US | claimed |
| EP-2125796-A1 | FURAZANE DERIVATIVES, PREPARATION THEREOF AND ENERGETIC COMPOSITIONS CONTAINING THEM | SNPE Matériaux Energétiques (FR) | 2009-12-02 | — | — | EP | claimed |
| WO-2008102092-A1 | FURAZANE DERIVATIVES, PREPARATION THEREOF AND ENERGETIC COMPOSITIONS CONTAINING THEM | SNPE MATERIAUX ENERGETIQUES (FR) | 2008-08-28 | — | — | WO | claimed |
| US-8211252-B2 | Furazane derivatives, preparation thereof and energetic compositions containing them | EURENCO (FR) | 2012-07-03 | — | — | US | disclosed |
| US-20100132856-A1 | FURAZANE DERIVATIVES, PREPARATION THEREOF AND ENERGETIC COMPOSITIONS CONTAINING THEM | SNPE MATERIAUX ENERGETIQUES (FR) | 2010-06-03 | — | — | US | disclosed |
| EP-2125796-A1 | FURAZANE DERIVATIVES, PREPARATION THEREOF AND ENERGETIC COMPOSITIONS CONTAINING THEM | SNPE Matériaux Energétiques (FR) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008102092-A1 | FURAZANE DERIVATIVES, PREPARATION THEREOF AND ENERGETIC COMPOSITIONS CONTAINING THEM | SNPE MATERIAUX ENERGETIQUES (FR) | 2008-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100132856-A1 | FURAZANE DERIVATIVES, PREPARATION THEREOF AND ENERGETIC COMPOSITIONS CONTAINING THEM | NOX5, COX5A, TXN2 | CA12 4413/4885CA1 1875/4885CA2 2421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.